|
The insight advantage commercial biopharma leaders around the globe rely on most Keeping up with the fast-moving biopharmaceutical markets is essential for your success. But it isn’t an easy task. Which is why you need Scrip.
From licensing, to clinical trials, to competitor activity, from biotech start-ups to multinational giants, from the US to Europe to Asia Pacific, Latin America and beyond -
|
 |
GLOBAL CONTENT FROM TRUSTED EXPERTSResearched and written by 40+ journalists and analysts publishing around the clock and located across the globe, our teams cover the spectrum of global commercial news – from licensing, to clinical trials, to competitor activity. |
 |
INSIGHT BEYOND THE HEADLINESFocused on what’s behind the headlines - the strategic implications of global commercial pharma news – so you can see what developments actually mean for your business. |
 |
UNPARALLELED ACCESS TO DATA AND DECISION-MAKERSSupplemented with best-in class proprietary data, and an impressive network of key decision makers and industry leaders. |
 |
POWERFUL DIGITAL PLATFORMNew user-friendly, digital platform that is responsive to any mobile device includes a robust, multifaceted Boolean search and the ability to create custom email alerts. |
|
YOUR QUESTIONS ANSWERED: |
|||
SCRIP GIVES YOU:
PIPELINE WATCH: R&D progress for essential competitor data and drug strategy development PLUS
SCRIP 100: annual in-depth look at the performance and prospects of the global pharmaceutical industry ANDASK THE ANALYST: Exclusive service where our clients can ask our expert journalists and analysts questions about any of our news stories, data and analysis when they need additional information
|
 |
Video, audio, and proprietary data sets br ing our articles and analyses to life.
Numerous search filters allow for precise content targeting, and articles and searches can be saved and shared with one-click
Set custom email alerts on any topic or search criteria so you never miss what you need to know most. |
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.